igTherapeutics® Pharmaceutical R&D Services

About Intact Genomics

Intact Genomics is a privately held, revenue-generating biotech firm that operates as a hybrid platform, services, and diagnostics company. Its core innovation is the Fungal Artificial Chromosome (FAC) technology, enabling the capture and heterologous expression of large DNA fragments up to 300-500 kb for natural product discovery. The company commercializes a broad catalog of research reagents while offering custom R&D services through its igTherapeutics® division, targeting novel drug discovery from fungal and environmental microbiomes. With ISO-certified manufacturing and a focus on cutting-edge isothermal amplification and cloning tools, Intact Genomics supports academic, agricultural, and pharmaceutical research sectors.